Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

About Cancer Care Business Exchange

About Cancer Care Business Exchange

 

The Cancer Care Business Exchange (CBEx) is a high-level, multistakeholder forum focusing on the business implications of the changing complexities in cancer care delivery and payment. It includes conversations between thought leaders who have interest, influence, and impact on cancer care delivery, including policymakers, payers, cancer center executives, clinicians, technology providers, and employers.

This educational and research forum focuses on trends and breaking developments in the business of cancer care. CBEx aims to tackle the changing ecosystem of cancer care and apply fresh perspective, innovation, and opportunities to improve care costs, risk, delivery, patient experience, and outcomes. This give-and-take dialogue and discussion is highlighted year-round through the Cancer Care Business Breakthroughs video series and culminates in a focus on these leading-edge topics at the annual Clinical Pathways Congress, where the content covered by CBEx is featured in live presentations by high-profile industry experts.

 

About the Clinical Pathways Congress + CBEx

The 2023 Clinical Pathways Congress debuted a new partnership with CBEx. In 2024, this continuing collaboration expands the conversation to the stakeholders who have interest, influence, and impact on the evolving business models of cancer care, and how innovation will continue to improve them.

Learn More | Conference Leaders

Meet the Executive Advisory Board

 

The CBEx Board includes providers, administrators, educators, and experts with decades of experience in oncology and a passion to drive meaningful change.

 

Barry Russo
Barry Russo, MBA
The Center for Cancer and Blood Disorders 
Fort Worth, TX
Deirdre Saulet
Deirdre Saulet, PhD
Carrum Health
Richmond, VA
Ronald Barkley
Ronald Barkley, MS, JD
Cancer Center Business Development Group
Vero Beach, FL
Carla Balch
Carla Balch, MS
Spesana
Memphis, TN
Alexis Bortniker
Alexis Bortniker, JD
Foley & Lardner LLP
San Diego, CA
Nina Chavez
Nina Chavez, MBA
Flatiron Health
Albuquerque, NM
Rushir Choksi
Rushir Choksi, MD
University of Pittsburgh Medical Center
Pittsburgh, PA
James Hamrick
James Hamrick, MD, MPH
Flatiron Health
Atlanta, GA
John E. Hennessy
John E. Hennessy, MBA
Valuate Health Consultancy 
Overland Park, KS
Andrew Hertler
Andrew Hertler, MD, FACP
New Century Health
Brea, CA
Manasi Kapoor
Manasi Kapoor, MBA
Memorial Sloan Kettering
New York, NY
Ira Klein
Ira Klein, MD
Tempus Labs 
Chicago, IL
Michael Kolodziej
Michael Kolodziej, MD
ADVI
Washington, DC
Harlan Levine
Harlan Levine, MD
City of Hope
Duarte, CA
Barbara McAneny
Barbara McAneny, MD
New Mexico Oncology Hematology Consultants, Ltd
Albuquerque, NM
Erich Mounce
Erich Mounce, MSHA
Oncology Care Partners 
La Grange, TN
Ed Rodgers
Ed Rodgers
ClinicalPath/Elsevier
Pittsburgh, PA
Todd Schonherz
Todd Schonherz
American Oncology Network
Fort Myers, FL
Adria Warren
Adria Warren, JD
Foley & Lardner LLP
Boston, MA 
 

Advertisement

Advertisement